Jump to Navigation
Trends and Sentiments
Comments and Analysis
Microsoft accidentally reveals the next version of...
Agrochem cos send legal notice to Greenpeace India
100 days of Narendra Modi govt: 10 hits and misses
Futures Movers: Oil weak after overnight slump; Brent...
India smartphone wars: Google Android One adds to Samsung...
The 10 Most Important Things In The World Right Now
Using Yahoo As A Unique Way To Capitalize On The Upcoming...
Councillors approve plans to buy former prison
Know what's 'right' for better banking
After nude celebrity photos leak, Apple Inc washes hands...
Good News for Vical Cancer Drug Candidate
Vical, Inc. Q4 2009 Earnings Call Transcript
Biotech Deal Activity Takes a Breather
7 Companies in the Race to Find Cures for Cancer
Vical Incorporated Q1 2010 Earnings Call Transcript
Vical Incorporated. Q2 2010 Earnings Call Transcript
Sanofi Failure Opens Door for Aastrom Bio
Bottom Fishing: Any Value in September's Losers?
15 Biotech Stocks With the Lowest Put/Call Ratios
Vical Analyst and Investor Day Transcript
Seven Stocks With CEO Buying in the Past Week
Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript
18 Stocks on the 52 Week Low List Ready to Pop?
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Vical Is Deeply Undervalued: Technology and Pipeline Offer Upside Reward
Major FDA Approval Could Pave the Way for These 5 Biotechs
Vical: A Biotech Flying Under the Radar
Chinese CEOs: Cook Your Books at Your Own Peril
7 Dirt Cheap Biotech Stocks With Huge Upside
Breakouts: 6 Stocks Showing New Strength
Vical's CEO Discusses Q1 2011 Results - Earnings Call Transcript
4 Biotech Stocks with Extremely Bearish Options Sentiment
Personalized Medicine for the Masses
Careful Analysis Reveals Good Probability of Gains for Vical
Growth feels good for Principle
Endless backs Gradus MBO
EUR/GBP: 1.2547 USD/EUR: 1.3133 JPY/USD: 104.995
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions